⌘K

Eli Lilly and Company (LLY)

$584.04 -1.18% $-7.00 Healthcare

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Market cap

$554.43B

CEO

Mr. David A. Ricks

Full time employees

35,000.00

Headquarters

Indianapolis, IN

IPO Date

Jul 09, 1970

Price-to-earnings (PE) Ratio

106.19

Earnings-per-share (EPS)

$5.50

Cash ratio (TTM)

0.11

Current ratio (TTM)

1.05

Dividend yield (TTM)

0.76%

Earnings yield (TTM)

0.94%

Net profit margin (TTM)

15.55%

PE ratio (TTM)

106.89

PEG ratio (TTM)

-0.63

Price-to-book ratio (TTM)

47.52

Price-to-sales ratio (TTM)

17.54

Quick ratio (TTM)

0.58

Return on assets (TTM)

8.61%

Return on equity (TTM)

45.22%

Similar stocks (7)

Johnson & Johnson

JNJ

$158.38 2.41% $3.72

Downtrend

Merck & Co., Inc.

MRK

$103.46 0.96% $0.98

Downtrend

AbbVie Inc.

ABBV

$143.41 0.72% $1.02

Downtrend

Pfizer Inc.

PFE

$28.91 -5.12% $-1.56

Downtrend

Amgen Inc.

AMGN

$272.45 1.04% $2.81

Uptrend

Bristol-Myers Squibb Company

BMY

$50.10 1.46% $0.72

Downtrend

Gilead Sciences, Inc.

GILD

$77.65 1.37% $1.05

Downtrend

ETF Exposure (38)

iShares U.S. Healthcare ETF

IYH

9.89712%

$275.65 0.50% $1.36

Downtrend

Health Care Select Sector SPDR Fund

XLV

9.664158%

$131.83 0.40% $0.52

Neutral

Vanguard PRIMECAP Core Fund Investor Shares

VPCCX

9.16%

$31.97 0.79% $0.25

Uptrend

Vanguard Health Care Index Fund

VHT

8.55%

$240.15 0.65% $1.55

Downtrend

iShares Global Healthcare ETF

IXJ

6.90024%

$84.06 0.39% $0.33

Downtrend

Invesco Dynamic Pharmaceuticals ETF

PJP

5.478%

$71.39 0.89% $0.63

Downtrend

VanEck Pharmaceutical ETF

PPH

5.24%

$78.72 0.27% $0.21

Downtrend

SPDR S&P Pharmaceuticals ETF

XPH

5.127857%

$37.61 1.65% $0.61

Downtrend

iShares MSCI USA Quality Factor ETF

QUAL

3.3679%

$141.91 0.60% $0.84

Uptrend

Invesco Dynamic Large Cap Growth ETF

PWB

3.219%

$75.52 0.49% $0.37

Uptrend

Vanguard Growth Index Fund

VUG

2.43%

$299.62 0.35% $1.05

Uptrend

Vanguard S&P 500 Growth Index Fund

VOOG

2.3%

$262.81 0.35% $0.92

Uptrend

SPDR Portfolio S&P 500 Growth ETF

SPYG

2.252861%

$63.12 0.37% $0.23

Uptrend

iShares S&P 500 Growth ETF

IVW

2.25234%

$72.84 0.36% $0.26

Uptrend

iShares Russell 1000 Growth ETF

IWF

2.18611%

$291.97 0.38% $1.11

Uptrend

iShares Global 100 ETF

IOO

2.14979%

$78.49 0.32% $0.25

Uptrend

iShares Core S&P U.S. Growth ETF

IUSG

2.1267%

$100.86 0.48% $0.48

Uptrend

iShares S&P 100 ETF

OEF

1.80017%

$216.18 0.26% $0.56

Uptrend

Vanguard Large Cap Index Fund

1.32%

$210.88 0.60% $1.25

Uptrend

SPDR S&P 500 ETF Trust

SPY

1.226535%

$459.10 0.59% $2.70

Uptrend

iShares Core S&P 500 ETF

IVV

1.2263%

$461.13 0.59% $2.71

Uptrend

Pacer Trendpilot US Large Cap ETF

PTLC

1.21%

$42.16 0.57% $0.24

Uptrend

iShares Russell 1000 ETF

IWB

1.18625%

$252.61 0.76% $1.90

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

1.16%

$111.09 0.85% $0.94

Uptrend

Vanguard Total Stock Market Index Fund

VTI

1.16%

$228.17 0.84% $1.91

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

1.16%

$111.07 0.85% $0.94

Uptrend

iShares Morningstar U.S. Equity ETF

ILCB

1.15648%

$63.43 0.63% $0.40

Uptrend

SPDR Portfolio S&P 1500 Composite Stock Market ETF

SPTM

1.125941%

$56.29 0.77% $0.43

Uptrend

iShares Russell 3000 ETF

IWV

1.12589%

$263.04 0.81% $2.11

Uptrend

iShares Dow Jones U.S. ETF

IYY

1.10777%

$112.18 0.70% $0.78

Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

1.05684%

$101.14 0.82% $0.82

Uptrend

iShares MSCI World ETF

URTH

0.82687%

$128.76 0.77% $0.98

Uptrend

Schwab Core Equity Fund

SWANX

0.7639029059%

$19.86 0.15% $0.03

Uptrend

SPDR Global Dow ETF

DGT

0.651595%

$115.57 0.80% $0.92

Neutral

Harbor Disruptive Innovation ETF

INNO

0.6%

$13.55 1.27% $0.17

Neutral

iShares MSCI Global Min Vol Factor ETF

ACWV

0.44877%

$99.25 0.49% $0.48

Neutral

Invesco S&P 500 Equal Weight ETF

RSP

0.195%

$150.53 1.50% $2.23

Neutral

iShares MSCI USA Equal Weighted ETF

EUSA

0.15965%

$80.23 1.61% $1.27

Neutral